Loading
Disease Relevant Readouts / Obesity · Journal article
Biomaterials · July 9, 2026
Raises a question worth testing. It does not answer one.
This is a narrative review surveying 3D in vitro adipose tissue models as research tools for obesity mechanistics and drug discovery. It does not report empirical findings, clinical outcomes, or comparative efficacy data; instead, it provides a roadmap of existing and emerging methodological approaches and interpretative frameworks.
Journal article. Obesity research; adipocytes and adipose tissue systems in vitro..
3D in vitro adipocyte models recapitulate lipid-laden, hypertrophic adipocyte phenotype characteristic of obesity, unlike traditional 2D monolayer systems where adipocytes detach. 3D platforms enable functional assays to validate obesity disease hallmarks and assess therapeutic interventions. Field faces critical challenge of integrating multiple disease-relevant readouts into holistic interpretations to unlock novel adipocyte-targeting mechanisms.
Safety was not reported in the material analysed. Check the source before drawing any conclusion about harm.
The source did not state who this applies to in practice.
This is a narrative review of in vitro methodology and mechanistic platforms, not a primary research study with empirical results or clinical outcomes.
Graded across the dimensions that decide whether you should act, each from what the source actually supports. There is no single score, and where a dimension was not assessed it says so.
What is missing. This record has no reported figures. That is a gap in the analysis, not a judgement about the study.
Obesity represents a complex systemic disease resulting in the global metabolic syndrome epidemic, yet our understanding of the underlying mechanisms in adipose tissue driving obesity remains limited. As the primary cellular targets of increased caloric intake, adipocytes undergo dramatic morphological and functional changes that trigger systemic metabolic dysfunction. To study the dysfunctional obese adipocyte phenotype in vitro, revolutionary three-dimensional (3D) adipocyte models have shown to be uniquely capable of recapitulating the lipid-laden, hypertrophic adipocyte characteristic of obesity. This feature makes 3D in vitro platforms powerful alternatives to traditional two-dimensional monolayer systems where the large, spherical and buoyant adipocytes simply detach. These sophisticated 3D in vitro New Approach Methodologies (NAMs) now enable researchers to dissect the multifactorial nature of obesity through diverse functional assays that validate individual disease hallmarks and assess therapeutic interventions. However, the field faces a critical challenge: integrating multiple disease-relevant readouts into holistic interpretations that can unlock novel adipocyte-targeting mechanisms. This review provides a comprehensive roadmap of cutting-edge 3D adipose tissue systems, showcasing how these NAMs can revolutionize biological and drug target discovery in obesity research. We examine the functional assays that define these models' capabilities, address key interpretative challenges, and explore transformative opportunities to amplify their impact through high-throughput approaches and scalable functional platforms that will accelerate the next generation of obesity therapies.
Taken from the source record, never inferred. Follow any of these and new work involving them reaches your briefing.